These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Molecular Simulation-Based Investigation of Highly Potent Natural Products to Abrogate Formation of the nsp10-nsp16 Complex of SARS-CoV-2. Mohammad A; Alshawaf E; Marafie SK; Abu-Farha M; Al-Mulla F; Abubaker J Biomolecules; 2021 Apr; 11(4):. PubMed ID: 33919870 [TBL] [Abstract][Full Text] [Related]
23. Natural Products Homoharringtonine and Emetine Alkaloids as SARS-CoV-2 Treatment Options. Sohrab SS; Suhail M; Kamal MA; Azhar EI Curr Pharm Des; 2021; 27(32):3444-3453. PubMed ID: 33302852 [TBL] [Abstract][Full Text] [Related]
24. Development of Broad-Spectrum Antiviral Agents-Inspiration from Immunomodulatory Natural Products. Zhang M; Zhong J; Xiong Y; Song X; Li C; He Z Viruses; 2021 Jun; 13(7):. PubMed ID: 34203182 [TBL] [Abstract][Full Text] [Related]
25. Promising natural products against SARS-CoV-2: Structure, function, and clinical trials. Zhao Y; Deng S; Bai Y; Guo J; Kai G; Huang X; Jia X Phytother Res; 2022 Oct; 36(10):3833-3858. PubMed ID: 35932157 [TBL] [Abstract][Full Text] [Related]
26. Plants and Natural Products with Activity against Various Types of Coronaviruses: A Review with Focus on SARS-CoV-2. Llivisaca-Contreras SA; Naranjo-Morán J; Pino-Acosta A; Pieters L; Vanden Berghe W; Manzano P; Vargas-Pérez J; León-Tamariz F; Cevallos-Cevallos JM Molecules; 2021 Jul; 26(13):. PubMed ID: 34279439 [TBL] [Abstract][Full Text] [Related]
27. Cyanobacterial natural products as sources for antiviral drug discovery against COVID-19. Jafari Porzani S; Konur O; Nowruzi B J Biomol Struct Dyn; 2022 Oct; 40(16):7629-7644. PubMed ID: 33749496 [TBL] [Abstract][Full Text] [Related]
28. Exploring algae and cyanobacteria as a promising natural source of antiviral drug against SARS-CoV-2. Sami N; Ahmad R; Fatma T Biomed J; 2021 Mar; 44(1):54-62. PubMed ID: 33640332 [TBL] [Abstract][Full Text] [Related]
29. Computational Determination of Potential Inhibitors of SARS-CoV-2 Main Protease. Ngo ST; Quynh Anh Pham N; Thi Le L; Pham DH; Vu VV J Chem Inf Model; 2020 Dec; 60(12):5771-5780. PubMed ID: 32530282 [TBL] [Abstract][Full Text] [Related]
33. Natural Products: A Rich Source of Antiviral Drug Lead Candidates for the Management of COVID-19. Wijayasinghe YS; Bhansali P; Viola RE; Kamal MA; Poddar NK Curr Pharm Des; 2021; 27(33):3526-3550. PubMed ID: 33213322 [TBL] [Abstract][Full Text] [Related]
34. Natural Flavonoids as Potential Angiotensin-Converting Enzyme 2 Inhibitors for Anti-SARS-CoV-2. Muchtaridi M; Fauzi M; Khairul Ikram NK; Mohd Gazzali A; Wahab HA Molecules; 2020 Sep; 25(17):. PubMed ID: 32882868 [TBL] [Abstract][Full Text] [Related]
35. The use of Pseudotyped Coronaviruses for the Screening of Entry Inhibitors: Green Tea Extract Inhibits the Entry of SARS-CoV-1, MERSCoV, and SARS-CoV-2 by Blocking Receptor-spike Interaction. Joseph J; Karthika T; Das VRA; Raj VS Curr Pharm Biotechnol; 2022; 23(8):1118-1129. PubMed ID: 34375189 [TBL] [Abstract][Full Text] [Related]
36. Active Learning and the Potential of Neural Networks Accelerate Molecular Screening for the Design of a New Molecule Effective against SARS-CoV-2. Yassine R; Makrem M; Farhat F Biomed Res Int; 2021; 2021():6696012. PubMed ID: 34124259 [TBL] [Abstract][Full Text] [Related]
37. IMU-838, a Developmental DHODH Inhibitor in Phase II for Autoimmune Disease, Shows Anti-SARS-CoV-2 and Broad-Spectrum Antiviral Efficacy In Vitro. Hahn F; Wangen C; Häge S; Peter AS; Dobler G; Hurst B; Julander J; Fuchs J; Ruzsics Z; Überla K; Jäck HM; Ptak R; Muehler A; Gröppel M; Vitt D; Peelen E; Kohlhof H; Marschall M Viruses; 2020 Dec; 12(12):. PubMed ID: 33291455 [TBL] [Abstract][Full Text] [Related]
38. Recent Advances in the Discovery of Potent Proteases Inhibitors Targeting the SARS Coronaviruses. Sharma A; Kaliya K; Maurya SK Curr Top Med Chem; 2021; 21(4):307-328. PubMed ID: 33183205 [TBL] [Abstract][Full Text] [Related]
39. Compounds of plants with activity against SARS-CoV-2 targets. Marmitt DJ; Goettert MI; Rempel C Expert Rev Clin Pharmacol; 2021 May; 14(5):623-633. PubMed ID: 33706626 [TBL] [Abstract][Full Text] [Related]
40. Bioactivity Potential of Marine Natural Products from Scleractinia-Associated Microbes and In Silico Anti-SARS-COV-2 Evaluation. Zahran EM; Albohy A; Khalil A; Ibrahim AH; Ahmed HA; El-Hossary EM; Bringmann G; Abdelmohsen UR Mar Drugs; 2020 Dec; 18(12):. PubMed ID: 33339096 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]